[Updated 2019 May 4]
By slowing the rate at which food moves from the stomach into the small intestine, tirzepatide helps regulate postprandial glucose excursions and promotes satiety
Strong R, Miller RA, Cheng CJ, Nelson JF, Gelfond J, Allani SK, Diaz V, Dorigatti AO, Dorigatti J, Fernandez E, Galecki A (2022) Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
Tirzepatide is a dual GIP/GLP-1 receptor agonist it mimics two naturally occurring hormones that regulate hunger and blood sugar
Understanding Semaglutide Semaglutide is a groundbreaking pharmaceutical agent, lauded for its effectiveness in treating type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)